Structure of neprilysin in complex with the active metabolite of sacubitril

51Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sacubitril is an ethyl ester prodrug of LBQ657, the active neprilysin (NEP) inhibitor, and a component of LCZ696 (sacubitril/valsartan). We report herein the three-dimensional structure of LBQ657 in complex with human NEP at 2 Å resolution. The crystal structure unravels the binding mode of the compound occupying the S1, S1' and S2' sub-pockets of the active site, consistent with a competitive inhibition mode. An induced fit conformational change upon binding of the P1'-biphenyl moiety of the inhibitor suggests an explanation for its selectivity against structurally homologous zinc metallopeptidases.

Cite

CITATION STYLE

APA

Schiering, N., D’Arcy, A., Villard, F., Ramage, P., Logel, C., Cumin, F., … Mogi, M. (2016). Structure of neprilysin in complex with the active metabolite of sacubitril. Scientific Reports, 6. https://doi.org/10.1038/srep27909

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free